H.M. Sampoerna Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? H.M. Sampoerna Tbk. trades at Rp730 (market cap 86.08T, 6.17M 24h volume), while Prodia Diagnostic Line Tbk trades at Rp236 (market cap 428.75B, 13.83M 24h volume). The key difference: H.M. Sampoerna Tbk. is far larger — about 200.8× Prodia Diagnostic Line Tbk's market cap, and Prodia Diagnostic Line Tbk is more actively traded (13.83M versus 6.17M). Which is the better fit depends on your goals.
| HMSP | PRDL | |
|---|---|---|
Market Cap | 86.08T | 428.75B |
Volume | 6.17M | 13.83M |
Lot | 61.7K | 138.27K |
Turnover | 4.52B | 3.27B |
Average Price | 732.19 | 236.62 |
Value | 4.52B | 3.27B |
Indicative Equilibrium Price | 730 | 236 |
Indicative Equilibrium Volume | 3.68K | 1.74K |
Trailing returns across standard periods
Latest headlines on both assets
PT Hanjaya Mandala Sampoerna Tbk (the Company) was established in Indonesia on October 19, 1963 based on Notarial Deed No. 69 of Anwar Mahajudin, S.H.. The Company started its commercial operation since 1913 in Surabaya, as a home industry. In 1930, this home industry was officially organized under the name of NVBM Handel Maatschapij Sampoerna.
Read more on HMSP →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →